Dr. Jin Lei, Ph.D., is a Chinese businessman, the self-made billionaire CEO of GenSci Pharmaceutical (a major manufacturer of recombinant human growth hormone), which is merged with Changchun High & New Technology Industries Group (SZSE: 000661). His career is rooted in elite biomedical research and pharmaceutical manufacturing.

Jin holds a master's degree from the Chinese Academy of Sciences and a Ph.D. from the University of California. After receiving his doctorate, Jin worked for the renowned biomedical firm Genentech in the U.S., gaining crucial experience in advanced biotech R&D and operations. He returned to China in 1995 to apply his global expertise to the domestic pharmaceutical market.

• GenSci Pharmaceutical (CEO): The core private asset, a major manufacturer of recombinant human growth hormone (merged with Changchun High & New Technology Industries Group).
• Biotech Focus: His success is built on R&D and manufacturing of recombinant human growth hormone (a high-value specialty drug).
• Academic Background: He holds a Ph.D. from the University of California and worked at Genentech in the U.S.
• Investment Strategy: His philosophy is rooted in long-term investment in biomedical R&D and catering to the domestic Chinese healthcare market.

Dr. Jin Lei returned to China in 1995 and co-founded GeneScience Pharmaceuticals in 1996, securing funding from Changchun High and New Technology. His strategic genius was his commitment to high-end biotech manufacturing (e.g., human growth hormone), filling a key niche in the Chinese pharmaceutical market. The company successfully went public by merging with the Shenzhen-listed Changchun High & New Technology Industries Group in 2019.

As CEO of GenSci Pharmaceutical, Jin's structural contribution is tied to the successful industrialization of complex biomedical products in China, leveraging his Western R&D expertise. His wealth is secured by the long-term, stable profitability of the specialty drug and human growth hormone market.

Dr. Jin Lei's social impact is structural, stemming from GenSci Pharmaceutical's role in providing essential human growth hormone treatments for patients in China, improving public health outcomes. The company provides thousands of stable R&D and manufacturing jobs.

His career is a testament to the profitability of disciplined biomedical entrepreneurship and the successful transfer of advanced Western biotech R&D to the Chinese market.

Jin Lei maintains the professional, composed style of a technology executive. His attire is consistently formal and high-quality, favoring tailored business suits. His aesthetic reflects serious authority and stability, typical of a leader in the highly specialized biotech sector.

Residing in China, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to biotechnology innovation, strategic management, and the long-term, stable growth of the specialty drug market.